Health minister inaugurates projects worth Rs 11.6 crore in Dharmapuri district
Speaking at the meeting, Subramanian said, "Since the DMK government came to power, Chief Minister MK Stalin has taken steps to improve the infrastructure of all hospitals across the state. As testament to this, in Dharmapuri, we inaugurated 11 projects, including a new MRI unit in DMCH. A pay ward with 50 beds has also been introduced. We have also constructed a special observation ward for postnatal mothers and children, and other projects worth Rs 12.63 crores. Moreover, since Stalin took charge, 11 government medical college hospitals have seen infrastructure upgrades worth Rs 4,722.51 crore."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Prostate health in focus as BPH drug demand rises in Gujarat
Ahmedabad: The sale of drugs used to treat benign prostatic hyperplasia (BPH)—a non-cancerous enlargement of the prostate gland—has surged by 70% over the past four years, indicating a significant rise in cases across the state. According to data from Pharmarack, the moving annual total (MAT) for BPH drugs was Rs 55.24 crore in June 2021, which rose to Rs 93.93 crore in June this year. The MAT for the overall urology segment also saw a 42% increase, from Rs 115.22 crore to Rs 164.2 crore during the same period. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "BPH affects a significant portion of men aged 50 and above, causing urinary difficulties and impacting quality of life. While the condition has always existed, the sharp rise in diagnosed cases and medical interventions reflects broader trends," said a pharmaceutical distributor who requested anonymity. Industry sources said that pharma companies have improved drug delivery through fixed-dose combinations, leading to better patient compliance and outcomes. The most common prescriptions now include alpha-blockers and 5-alpha-reductase inhibitors, which help alleviate symptoms and slow further prostate growth, Pharmarack data indicated. According to urologists in Ahmedabad, men are increasingly addressing symptoms of an enlarged prostate rather than ignoring them. The stigma around men's urological health is gradually diminishing, especially in urban and semi-urban areas. Dr Rohit Bhattar, a uro-onco surgeon at a city-based private hospital, said, "There has been a significant rise in BPH cases over the past decade. While traditionally considered a disease of old age, we are now seeing some patients even under the age of 50, often due to other health conditions and lifestyle factors. Greater awareness today also plays a role compared to a decade ago." While metros and Tier-I cities initially drove demand for BPH drugs, pharmaceutical industry sources report that Tier-II cities and rural areas are now seeing growing traction. Dr Hemang Bakshi, another uro-onco surgeon, noted, "The rise in drug sales must be viewed in the context of increased life expectancy. Medications are often prescribed to maintain or enhance prostate function over time. Since onset typically occurs around the age of 60, patients may remain on treatment for several years. This extended treatment duration is a contributing factor. We've certainly seen a decadal rise in the incidence of the condition. " Experts say improvements in healthcare access and preventive diagnostics in Gujarat have made a noticeable impact. Routine check-ups, ultrasounds, and PSA tests are increasingly being used to detect prostate issues at earlier stages.
Time of India
3 hours ago
- Time of India
6 PHED engrs served notice over 150 crore tubewell scam in Jalore
Jaipur: Public health engineering department (PHED) has issued notices to six engineers of the department, including a retired engineer, for alleged involvement in a scam of Rs 150 crore. Officials said these engineers reportedly gave Operations and Maintenance (O&M) tenders to two firms for more than 900 tubewells in Jalore district when they were entitled to O&M of only 20 tubewells. "We took up the issue with PHED minister Kanhaiya Lal Choudhary. Following his instructions, we are going to take major steps against these accused engineers. We will also lodge complaints with police in this regard," disclosed a senior PHED official Wednesday. An official of the department claimed that the accused—then executive engineers Umesh Kumar Meena, Shyam Bihari Bairwa, Jitendra Trivedi, Hemant Kumar Bairwa, Ashish Dwivedi (retd), and Hemant Kumar Vaishnav—gave the work orders for O&M of 981 tubewells on Aug 12, 2022, to two firms—MM Construction and MS Raj Enterprise. "In gross violation of norms, the then superintendent engineer of the circle issued this work order for 981 tubewells. The two firms should have got work orders for only 20 tubewells. For the last three years, the department is unnecessarily wasting money on O&M expenditure for such a huge number of additional tubewells. The department has also blacklisted the two firms," the official added. Investigation revealed that PHED bore O&M expenditure for around 3,500 tubewells in Jalore for the last three years, when the actual number of tubewells of the department in the district was only close to 1,500.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Narayana Health to add 2,000 beds, expand insurance schemes in FY26
Bengaluru-headquartered hospital chain Narayana Health aims to grow its domestic revenue by 10 per cent in FY26, in line with industry benchmarks, a senior company official said. Managing director and chief executive officer Emmanuel Rupert told Business Standard: 'Last fiscal we did about Rs 4,349 crore in India revenue and we want to grow at a rate at which the healthcare industry is growing — over 10 per cent. We look to be on the same momentum and revenue.' Sandhya J, chief financial officer at Devi Shetty's Narayana Health, said the company plans to scale up its Aditi and Arya health insurance schemes in Karnataka and West Bengal. 'The entire healthcare ecosystem is failing in trust. We are on the path to solve the trust deficit and episodic interference of fund transfer. On the back of this, we aim to double down on our insurance scheme and build a strong customer base in Bengaluru, Shivamogga, Mysore, and Kolkata.' Commenting on efforts to improve profit after tax (PAT), which declined 2.3 per cent to Rs 196 crore in Q1 due to increased investments in integrated care and other financial costs, Sandhya said PAT optimisation will improve as the India business grows. Some clinics have started breaking even, reducing losses from the health insurance schemes. 'Over a period of time, we will be able to keep the losses in check and expand margins in the domestic business. PAT should improve. Finance cost will continue to increase due to the Rs 3,000 crore project to add 2,000 beds across India over the next three years. The integrated care dilution will continue over the next year but we hope to maintain a decent level of cash burn.' She added that a large part of the funding will come through bank borrowings and non-convertible debentures (NCDs) as needed. So far, Rs 800 crore has been raised for projects already signed. The CFO noted that about Rs 1,500–2,000 crore in loans might be raised in this fiscal, depending on upcoming project developments. 'We are exploring opportunities to expand, some might be inorganic as well. Borrowings will be linked to the construction progress of our current projects.' During the quarter, revenue from international patients declined, primarily due to reduced footfall from Bangladesh. Narayana expects this trend to continue, given ongoing geopolitical tensions. 'The goal is to keep focusing on domestic growth and see how well we can push the numbers. Eventually, in the next two to three years, we believe that revenue contribution from Bangladesh will go down to zero. Not to miss, the country is building its own healthcare infrastructure.' Looking ahead, Narayana expects its integrated care business to account for a larger share of overall revenue. At present, cardiac sciences and oncology contribute approximately 33 per cent and 16 per cent, respectively. On Tuesday, the Clinical Research team and Medha AI developed an artificial intelligence (AI) model that predicts left ventricular ejection fraction from ECG images, enabling early heart failure detection and improved diagnostic access. 'All along we have waited for Western countries to develop these technologies. Today we are developing this because this country is blessed with phenomenally skilled, passionate software engineers and AI experts. This is our strength. We have made massive investments in building the digital platform, which is far ahead of all the other hospitals. With the great combination of a digital platform and the AI tool, healthcare will never be the same,' said Devi Prasad Shetty, chairman and founder of Narayana Health, at a media briefing. The company said that trained on over 100,000 ECG images paired with echocardiogram reports, the model showed strong predictive performance. With external validation across 14 tertiary centres and over 57,000 patients, it identified 97 per cent of individuals with severely reduced ejection fraction (≤35 per cent).
